User:Derica.parathundil/sandbox: Difference between revisions
Jump to navigation
Jump to search
Content deleted Content added
| Line 3: | Line 3: | ||
=== Ototoxicity of cancer treatment (chemo/radiation therapy) === |
=== Ototoxicity of cancer treatment (chemo/radiation therapy) === |
||
Cancer treatment has both immediate and late effects that impact quality of life if left untreated. These can include hearing loss, tinnitus and balance problems. Consensus for clinical care, enhanced tools and health promotion are needed to manage ototoxicity from cancer treatment. This group's goals are to develop a roadmap/call to action to a global template for implementation of ototoxicity management for cancer treatment, identify solutions to address gaps in ototoxicity research and management across the lifespan (including impacts to quality of life beyond hearing loss and recognition of immediate and late effects), identify effective tools, policy enhancements, and delivery frameworks for universal ototoxicity management, and develop resources and strategies that educate, empower, and engage stakeholders (including patients, families, and care teams). |
|||
=== Aminoglycoside-induced ototoxicity === |
=== Aminoglycoside-induced ototoxicity === |
||
Patients who are treated with aminoglycosides are more likely to develop hearing loss, tinnitus and/or balance problems than those who do not receive aminoglycoside treatment. Patients are not routinely monitored for hearing loss, tinnitus and/or balance problems. This group's goals are to collate/review existing recommendations, work with patients and providers to develop recommendations for applying audiology practice guidelines for ototoxicity management in patients treated with aminoglycosides, survey patients and providers regarding the acceptance and utility of recommendations, and submit consensus document for publication. |
|||
Relevant publications: |
|||
* '''''[https://pubs.asha.org/doi/abs/10.1044/2020_AJA-20-00059 "Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort"]''''' AJA, 2021 Jan 19;1-20. doi: 10.1044/2020_AJA-20-00059 |
|||
* [https://www.jmcp.org/doi/full/10.18553/jmcp.2021.27.2.157 "'''''Cost-effectiveness of implementing routine hearing screening using a tablet audiometer for pediatric cystic fibrosis patients receiving high-dose IV aminoglycosides'''''"] JMCP, Volume 27 Issue (2) Huang, McKinzie, Tak |
|||
* "[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996762/ '''''An Ototoxicity Grading System Within a Mobile App (OtoCalc) for a Resource-Limited Setting to Guide Grading and Management of Drug-Induced Hearing Loss in Patients With Drug-Resistant Tuberculosis: Prospective, Cross-Sectional Case Series'''''"] (Monitoring Editor: Gunther Eysenbach) |
|||
* [https://www.ncrar.research.va.gov/Documents/Hemmativaghef2020.pdf "'''''Exposure to lead, mercury, styrene, and toluene and hearing impairment: Evaluation of dose-response relationships, regulations, and controls'''''"] (by Ehsan Hemmativaghef) |
|||
=== Environmental and occupational ototoxicants === |
=== Environmental and occupational ototoxicants === |
||
There are no standard methods for the auditory surveillance of individuals exposed to environmental or occupational chemicals. Consensus guidelines for the clinical care of exposed persons and tools for implementation and health promotion are needed to manage ototoxicity from environmental and occupational exposures. This group's goals are to collate existing recommendations, update reviews, work with stakeholders in the fields of occupational health, hearing care and audiology to develop recommendations for applying audiology practice guidelines for ototoxicity management at work and in the clinic, and submit this consensus document for publication. |
|||
Relevant publications: |
|||
* [https://gupea.ub.gu.se/bitstream/handle/2077/23240/gupea_2077_23240_1.pdf;jsessionid=511239680796A22B3414C59156BCA5B7?sequence=1 '''Chapter 142. Occupational exposure to chemical and hearing impairment'''] from ''The Nordic Expert Group for Criteria Documentation of Health Risks from Chemical'' |
|||
* |
|||
=== International considerations === |
=== International considerations === |
||
Patients treated with ototoxic medications get their healthcare differently depending on the health care structures in their regions and their access to care. Practice recommendations and implementation toolkits tailored to the healthcare structures and global region are needed to increase access and value of ototoxicity management. This group's goals are to collate/review existing recommendations, survey patients and providers to develop recommendations for applying ototoxicity management guidelines in different health care structures and global regions, and submit findings for publication. |
|||
== Members of IOMG == |
== Members of IOMG == |
||
Revision as of 15:12, 12 July 2024
Focus areas
Ototoxicity of cancer treatment (chemo/radiation therapy)
Cancer treatment has both immediate and late effects that impact quality of life if left untreated. These can include hearing loss, tinnitus and balance problems. Consensus for clinical care, enhanced tools and health promotion are needed to manage ototoxicity from cancer treatment. This group's goals are to develop a roadmap/call to action to a global template for implementation of ototoxicity management for cancer treatment, identify solutions to address gaps in ototoxicity research and management across the lifespan (including impacts to quality of life beyond hearing loss and recognition of immediate and late effects), identify effective tools, policy enhancements, and delivery frameworks for universal ototoxicity management, and develop resources and strategies that educate, empower, and engage stakeholders (including patients, families, and care teams).
Aminoglycoside-induced ototoxicity
Patients who are treated with aminoglycosides are more likely to develop hearing loss, tinnitus and/or balance problems than those who do not receive aminoglycoside treatment. Patients are not routinely monitored for hearing loss, tinnitus and/or balance problems. This group's goals are to collate/review existing recommendations, work with patients and providers to develop recommendations for applying audiology practice guidelines for ototoxicity management in patients treated with aminoglycosides, survey patients and providers regarding the acceptance and utility of recommendations, and submit consensus document for publication.
Relevant publications:
- "Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort" AJA, 2021 Jan 19;1-20. doi: 10.1044/2020_AJA-20-00059
- "Cost-effectiveness of implementing routine hearing screening using a tablet audiometer for pediatric cystic fibrosis patients receiving high-dose IV aminoglycosides" JMCP, Volume 27 Issue (2) Huang, McKinzie, Tak
- "An Ototoxicity Grading System Within a Mobile App (OtoCalc) for a Resource-Limited Setting to Guide Grading and Management of Drug-Induced Hearing Loss in Patients With Drug-Resistant Tuberculosis: Prospective, Cross-Sectional Case Series" (Monitoring Editor: Gunther Eysenbach)
- "Exposure to lead, mercury, styrene, and toluene and hearing impairment: Evaluation of dose-response relationships, regulations, and controls" (by Ehsan Hemmativaghef)
Environmental and occupational ototoxicants
There are no standard methods for the auditory surveillance of individuals exposed to environmental or occupational chemicals. Consensus guidelines for the clinical care of exposed persons and tools for implementation and health promotion are needed to manage ototoxicity from environmental and occupational exposures. This group's goals are to collate existing recommendations, update reviews, work with stakeholders in the fields of occupational health, hearing care and audiology to develop recommendations for applying audiology practice guidelines for ototoxicity management at work and in the clinic, and submit this consensus document for publication.
Relevant publications:
- Chapter 142. Occupational exposure to chemical and hearing impairment from The Nordic Expert Group for Criteria Documentation of Health Risks from Chemical
International considerations
Patients treated with ototoxic medications get their healthcare differently depending on the health care structures in their regions and their access to care. Practice recommendations and implementation toolkits tailored to the healthcare structures and global region are needed to increase access and value of ototoxicity management. This group's goals are to collate/review existing recommendations, survey patients and providers to develop recommendations for applying ototoxicity management guidelines in different health care structures and global regions, and submit findings for publication.
Members of IOMG
- Dawn Konrad-Martin, Ph.D.
- Overall Chair of IOMG
- National Center for Rehabilitative Auditory Research and Oregon Health & Science University
- Portland, Oregon, United States of America
- Khaya Clark, Ph.D.
- Director of Dissemination
- National Center for Rehabilitative Auditory Research and Oregon Health & Science University
- Portland, Oregon, United States of America
- Lucretia Peterson, Ph.D.
- Co-chair of International Emphasis
- University of Cape Town
- Cape Town, South Africa
- Laura Dreisbach, Ph.D.
- Co-Chair of International Emphasis | Liaison for American Speech-Language Hearing Association
- San Diego State University
- San Diego, California, United States of America
- Angela Garinis, Ph.D.
- Chair of Ototoxicity of Aminoglycoside Treatment
- National Center for Rehabilitative Auditory Research and Oregon Health & Science University
- Portland, Oregon, United States of America
| Member Name | Role | Affiliation | Location |
|---|---|---|---|
| IOMG Leadership | |||
| Dawn Konrad-Martin, Ph.D. | Overall Chair of IOMG | National Center for Rehabilitative Auditory Research (NCRAR), Oregon Health & Science University (OHSU) | Portland, Oregon, United States of America |
| Khaya Clark, Ph.D. | Director of Dissemination | National Center for Rehabilitative Auditory Research (NCRAR), Oregon Health & Science University (OHSU) | Portland, Oregon, United States of America |
| Lucretia Peterson, Ph.D. | Co-chair of International Emphasis | University of Cape Town | Cape Town, South Africa |
| Laura Dreisbach, Ph.D. | Co-Chair of International Emphasis, Liaison for American Speech-Language Hearing Association | San Diego State University | San Diego, California, United States of America |
| Angela Garinis, Ph.D. | Chair of Ototoxicity of Aminoglycoside Treatment | National Center for Rehabilitative Auditory Research (NCRAR), Oregon Health & Science University (OHSU) | Portland, Oregon, United States of America |
| Gayla L. Poling, Ph.D. | Co-Chair of Ototoxicity of Cancer Treatment | National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes for Health (NIH) | Bethesda, Maryland, United States of America |
| Carmen Brewer, Ph.D. | Co-Chair of Ototoxicity of Cancer Treatment | National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes for Health (NIH) | Bethesda, Maryland, United States of America |
| Thais C. Morata, Ph.D. | Co-Chair of Environmental and Occupational Exposures | National Institute for Occupational Safety & Health (NIOSH), Centers for Disease Control and Prevention (CDC) | Cincinnati, Ohio, United States of America |
| Adrian Fuente Contreras, Ph.D. | Co-Chair of Environmental and Occupational Exposures | University of Montreal | Montreal, Canada |
| Deborah Berndtson, Au.D. | Patient Ambassador | American Speech-Language-Hearing Association (ASHA) | Rockville, Maryland, United States of America |
| Hunter Steuhm, Au.D. | Administrative Officer | National Center for Rehabilitative Auditory Research (NCRAR) | Portland, Oregon, United States of America |
| IOMG Membership | |||
| Ghada Al-Malky, Ph.D. | Member | Ear Institute at University College London | London, England |
| Ainul Naqueah Zainal Abdin | Member | University of Cyberjaya | Cyberjaya, Selangor, Malaysia |
| Katherine Bainbridge, Ph.D. | Member | National Institutes of Health (NIH) | Bethesda, Maryland, United States of America |
| Johnnie Bass, Au.D. | Member | St. Jude Children's Research Hospital | Memphis, Tennessee, United States of America |
| Keri O'Connell Bennett, Au.D. | Member | Multnomah Education Service District | Portland, Oregon, United States of America |
| Shukri Bin Mohd Aris | Member | University Technology MARA | Shah Alam, Selangor, Malaysia |
| Lindsey Bittinger, Au.D. | Member | University of Cincinnati | Cincinnati, Ohio, United States of America |
| Amy Boudin-George, Au.D. | Member | Hearing Center of Excellence, Defense Health Agency | San Antonio, Texas, United States of America |
| Beth Brooks, Au.D. | Member | Children's and Women's Health Centre | British Columbia, Canada |
| Emily Brown, Au.D. | Member | Hershel "Woody" Williams Veterans Affairs (VA) Medical Center | Huntington, West Virginia, United States of America |
| Anouk Burger | Member | Netherlands Cancer Institute (Antoni van Leeuwenhoek) | Amsterdam, Netherlands |
| Holly Burrows, Au.D. | Member | Walter Reed National Military Medical Center | Bethesda, Maryland, United States of America |
| Mavie Calvo, Au.D. | Member | Walter Reed National Military Medical Center | Bethesda, Maryland, United States of America |
| Krystin Carlson, Ph.D. | Member | National Institute for Occupational Safety & Health (NIOSH), Centers for Disease Control and Prevention (CDC) | Cincinnati, Ohio, United States of America |
| Jennifer Chisholm, Au.D. | Member | National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes for Health (NIH) | Bethesda, Maryland, United States of America |
| Zaida Crespo, Au.D. | Member | Carl Vinson Veterans Affairs (VA) Medical Center | Dublin, Georgia, United States of America |
| Lisa Cunningham | Member | National Institutes of Deafness and Other Communication Disorders (NIDCD), National Institutes for Health (NIH) | Bethesda, Maryland, United States of America |
| Amy Custer, Au.D. | Member | James Cancer Hospital at The Ohio State University Wexner Medical Center | Columbus, Ohio, United States of America |
| Riley DeBacker, Au.D., Ph.D. | Member | National Center for Rehabilitative Auditory Research (NCRAR), Oregon Health & Science University (OHSU) | Portland, Oregon, United States of America |
| Lauren Dillard, Au.D., Ph.D. | Member | Medical University of South Carolina | Charleston, South Carolina, United States of America |
| Katerina Ehlert | Member | Sefako Makgatho Health Sciences University | Ga-Rankuwa, Gauteng, South Africa |
| Neerja Erraguntla, Ph.D. | Member | American Chemistry Council | Washington, District of Columbia, United States of America |
| M. Patrick Feeney, Ph.D. | Member | National Center for Rehabilitative Auditory Research (NCRAR), Portland Veterans Affairs (VA) Medical Center | Portland, Oregon, United States of America |
| Katharine Fernandez, Ph.D., Au.D. | Co-Lead for Roadmap/Call to Action | National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes for Health (NIH) | Bethesda, Maryland, United States of America |
| Robert D. Frisina, Ph.D. | Member | Global Center for Hearing & Speech Research, University of South Florida - Tampa | Tampa, Florida, United States of America |
| Holly Gerth, Au.D. | Member | Nationwide Children's Hospital | Columbus, Ohio, United States of America |
| James Geller | Member | Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States of America |
| Valeria Goffi, Ph.D. | Member | University of Sao Paulo | Sao Paulo, Brazil |
| Wei Gong, M.S. | Member | National Institute for Occupational Safety & Health (NIOSH), Centers for Disease Control and Prevention (CDC) | Cincinnati, Ohio, United States of America |
| Amy Grosnik, Au.D. | Member | Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States of America |
| Logan Hays, Au.D. | Member | Central Arkansas Radiation Therapy Institute | Little Rock, Arizona, United States of America |
| Shakira Henderson, D.N.P., Ph.D., M.P.H. | Member | University of North Carolina (UNC) Health | Chapel Hill, North Carolina, United States of America |
| Marry van den Heuvel-Eibrink, M.D., Ph.D. | Member | Princess Máxima Center for Pediatric Oncology | Rotterdam, Netherlands |
| Kimberly Holden, Au.D. | Member | Lurie Children’s Hospital of Chicago | Chicago, Illinois, United States of America |
| Alex Hoetink, Ph.D. | Co-Lead for Roadmap/Call to Action | University Medical Center Utrecht for Audiology and Otology | Utrecht, Netherlands |
| Manja Hribar, M.D. | Member | University Medical Centre Ljubljana | Ljubljana, Slovenia |
| Michelle Hungerford, Au.D | Member | National Center for Rehabilitative Auditory Research (NCRAR) | Portland, Oregon, United States of America |
| Lisa Hunter, Ph.D. | Liaison for CFF (?) | Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States of America |
| Titus Ibekwe, M.B.B.S., M.P.H.H.P.M., F.W.A.C.S. | Member | University of Abuja-Nigeria | Abuja, Nigeria |
| Rajeev Jalvi | Member | ||
| Carmen Jamis, Au.D., CCC-A | Member | Head & Neck Institute at the Cleveland Clinic | Cleveland, Ohio, United States of America |
| Heather Johnson, Ph.D | Member | Mayo Clinic - Rochester | Rochester, Minnesota, United States of America |
| Christine Kaelin, M.B.H. | Member | National Center for Rehabilitative Auditory Research (NCRAR) | Portland, Oregon, United States of America |
| Veronica Kennedy, Au.D. | Member | Bolton National Health Service (NHS) Foundation Trust (FT) | Bolton, Greater Manchester, England |
| Hannah Keppler, Ph.D. | Member | Ghent University | Ghent, Belgium |
| Kate Kgwefane | Member | ||
| Julie Kinsman, Au.D | Member | Seattle Children’s Hospital | Seattle, Washington, United States of America |
| Kristin Knight, M.S., CCC-A | Lead for Pediatric Cancer Treatment(?)
Member |
Oregon Health & Science University (OHSU) | Portland, Oregon, United States of America |
| Maria Isabel Kós, Ph.D. | Member | Federal University of Rio de Janeiro | Rio de Janeirio, Brazil |
| Ajith Kumar | Member | ||
| Nisha KV | Member | ||
| Adriana Bender Moreira de Lacerda, Ph.D. | Member | University of Montreal | Montreal, Canada |
| Cecilia Lacey, Au.D. | Member | Pittsburgh Veterans Affairs (VA) Medical Center | Pittsburgh, Pennsylvania, United States of America |
| Wendy Landier, Ph.D., CRNP | Member | University of Alabama at Birmingham | Birmingham, Alabama, United States of America |
| Breana Langenek, B.A. | Member | The Ohio State University | Columbus, Ohio, United States of America |
| Megan Lappin, Au.D. | Member | St. Cloud Veterans Affairs (VA) Medical Center | St. Cloud, Minnesota, United States of America |
| Leah Leinbach, D.M.D, M.P.H. | Member | National Institutes for Health (NIH) | Bethesda, Maryland, United States of America |
| David Lee | Member | Washington University in St. Louis | St. Louis, Missouri, United States of America |
| John Lee, Ph.D., Au.D. | Member | National Institute On Deafness and Other Communication
Disorders (NIDCD), National Institutes for Health (NIH) |
Bethesda, Maryland, United States of America |
| Georgia Lester, Au.D. | Member | University of Queensland | Queensland, Australia |
| Dana Libman, Au.D. | Member | Emory University | Atlanta, Georgia, United States of America |
| Wanda Lugo-Velez, Au.D., CCC-A, F-AAA | Member | University of Puerto Rico | San Juan, Puerto Rico |
| Whitney Lyle, Au.D. | Member | Children’s Hospital Colorado | Aurora, Colorado, United States of America |
| Melissa MacAskill, M.A. | Member | l'Hôpital Necker-Enfants Malades
University of Paris |
Paris, France |
| Kelly Malcolm, Au.D. | Member | Harvard T.H. Chan School of Public Health | Cambridge, Massachusetts, United States of America |
| Faith Matarutso | Member | ||
| Ted Marras, M.D., M.Sc. | Member | Toronto Western Hospital | Toronto, Canada |
| Joscelyn Martin, Au.D. | Member | Mayo Clinic - Rochester | Rochester, Minnesota, United States of America |
| David R. Mattie, Ph.D., DABT | Member | Air Force Research Laboratory | Wright-Patterson Air Force Base, Ohio, United States of America |
| Catherine McMahon, Au.D | Member | Macquarie University | New South Wales, Sydney, Australia |
| Annelot Meijer, M.Sc. | Member | Princess Máxima Center | Utrecht, Netherlands |
| Rozela Melgoza, Au.D. | Member | Hearing Center of Excellence | West Falls Church, Virginia, United States of America |